Volume | 17,256 |
|
|||||
News | - |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
CERo Therapeutics Holdings Inc | CEROW | NASDAQ | Equity Warrant |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.0153 | 0.014001 | 0.0166 | 0.0143 | 0.0153 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume |
---|---|---|---|---|
19 | 17,256 | 0.0148371 | 256 | - |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:00:00 | 3 | 0.0153 | USD |
CERo Therapeutics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
95.56k | 6.25M | - | 0 | -2.54M | -0.41 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News CERo Therapeutics
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
CEROW Historical
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
CERo Therapeutics Holdings, Inc. is an immunotherapy company advancing the development of engineered T cell therapeutics for the treatment of cancer. The Company's proprietary approach to T cell engineering, enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, which is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its cellular immunotherapy platform is focused on redirecting patient-derived T cells to eliminate tumors by building in engulfment pathways that employ phagocytic mechanisms to destroy cancer cells, creating CERo, which is referred to as chimeric engulfment receptor t cells (CER-T). The Company is initiating clinical trials for its lead product candidate, CER-1236, for hematological malignancies. |
CEROW -
What is the current CERo Therapeutics Holdings Inc share price?
The current share price of CERo Therapeutics Holdings Inc is $ 0.0143
How many CERo Therapeutics Holdings Inc shares are in issue?
CERo Therapeutics Holdings Inc has 6,246,000 shares in issue
What is the market cap of CERo Therapeutics Holdings Inc?
The market capitalisation of CERo Therapeutics Holdings Inc is USD 95.56k
What is the 1 year trading range for CERo Therapeutics Holdings Inc share price?
CERo Therapeutics Holdings Inc has traded in the range of $ 0.00 to $ 0.00 during the past year
What is the PE ratio of CERo Therapeutics Holdings Inc?
The price to earnings ratio of CERo Therapeutics Holdings Inc is -14.41
What is the reporting currency for CERo Therapeutics Holdings Inc?
CERo Therapeutics Holdings Inc reports financial results in USD
What is the latest annual profit for CERo Therapeutics Holdings Inc?
The latest annual profit of CERo Therapeutics Holdings Inc is USD -2.54M
What is the registered address of CERo Therapeutics Holdings Inc?
The registered address for CERo Therapeutics Holdings Inc is RODNEY SQUARE, 1000 NORTH KING STREET, WILMINGTON, DELAWARE, 19801
What is the CERo Therapeutics Holdings Inc website address?
The website address for CERo Therapeutics Holdings Inc is www.cero.bio/
Which industry sector does CERo Therapeutics Holdings Inc operate in?
CERo Therapeutics Holdings Inc operates in the BLANK CHECKS sector